Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01177397
Title Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Celgene Corporation

estrogen-receptor positive breast cancer

neuroendocrine tumor

progesterone-receptor positive breast cancer

hepatocellular carcinoma


diffuse large B-cell lymphoma

Advanced Solid Tumor

multiple myeloma

Her2-receptor positive breast cancer

lung non-small cell carcinoma



Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
UCLA Neuro-Oncology Program Los Angeles California 90095 United States Details
University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center San Francisco California 94115 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Mayo Clinic Cancer Clinical Studies Unit Rochester Minnesota 55905 United States Details
Billings Clinic Billings Montana 59102 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
NYU Cancer Institute - Bellevue Hospital New York New York 10016 United States Details
Sarah Cannon Research Institute Drug Development Unit Nashville Tennessee 37203 United States Details
Mary Crowley Medical Research Center Dallas Texas 75201 United States Details
Institut Claudius Regaud Toulouse Cedex 31052 France Details
Institut Gustave Roussy Faculte de Medecine Paris Sud Service de pneumologie Villejuif 94800 France Details
Hospital Universitario de Salamanca Salamanca 37007 Spain Details
Hospital Universitario Virgen Del Rocio Sevilla 41013 Spain Details
Sarah Cannon Research Institute UK London W1G 6AD United Kingdom Details
UCL Cancer Institute London WC1E 6BT United Kingdom Details
*Shaded cells indicate that there was no data available from for the field